Texan Capital Management’s Pfizer PFE Stock Holding History

Texan Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$442K	Hold	12,862	–	–	0.29%	75
2017 Q3	$436K	Sell	12,862 -468	-4%	-$15K	0.29%	75
2017 Q2	$425K	Hold	13,330	–	–	0.29%	73
2017 Q1	$433K	Sell	13,330 -415	-3%	-$13.1K	0.2%	107
2016 Q4	$424K	Buy	+13,745	New	+$420K	0.2%	108
2016 Q3	–	Sell	-12,991	Closed	-$434K	–	139
2016 Q2	$434K	Hold	12,991	–	–	0.2%	103
2016 Q1	$371K	Sell	12,991 -611	-4%	-$17.5K	0.17%	106
2015 Q4	$417K	Buy	13,602 +1,096	+9%	+$34.5K	0.19%	105
2015 Q3	$373K	Hold	12,506	–	–	0.16%	119
2015 Q2	$398K	Buy	12,506 +468	+4%	+$15.3K	0.16%	114
2015 Q1	$397K	Buy	12,038 +140	+1%	+$4.45K	0.22%	89
2014 Q4	$352K	Sell	11,898 -1,918	-14%	-$55K	0.16%	97
2014 Q3	$388K	Buy	13,816 +886	+7%	+$24.9K	0.16%	101
2014 Q2	$364K	Hold	12,930	–	–	0.16%	110
2014 Q1	$394K	Hold	12,930	–	–	0.18%	115
2013 Q4	$376K	Sell	12,930 -867	-6%	-$25.2K	0.19%	109
2013 Q3	$376K	Hold	13,797	–	–	0.18%	118
2013 Q2	$367K	Buy	+13,797	New	+$381K	0.18%	117

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Texan Capital Management's PFE Position: Q4 2017 in Review

Texan Capital Management held its Pfizer (PFE) position steady in Q4 2017 at 12,862 shares worth $442K. The position accounts for 0.29% of the portfolio, ranked #75.

Texan Capital Management first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Texan Capital Management held 12,862 shares of Pfizer worth $442K as of Q4 2017.
Texan Capital Management left its Pfizer share count unchanged in Q4 2017.
Pfizer made up 0.29% of Texan Capital Management's portfolio in Q4 2017, its #75 holding.
Texan Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Texan Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.